Abdominal imaging in the UK almost always starts with an ultrasound. It is fast, cheap and available on the same day at most GP surgeries. For a lot of questions - is there a gallstone, is that liver cyst simple, is the kidney the right size - it is genuinely enough. The problem is that ultrasound answers a narrow band of questions well, and shrugs at the rest. That is where the choice between CT and MRI starts to matter.
This piece is the honest breakdown of when an abdominal MRI is the right test, when it is overkill, and where it quietly outperforms both ultrasound and CT for the specific problems patients face in 2026.
The one-line answer
Ultrasound for the first look. CT when it is fast, acute or systemic. MRI when the question is what exactly is that - and the answer needs high soft-tissue detail, duct anatomy, or serial follow-up without radiation.
Where ultrasound is enough
Ultrasound is not a lesser scan. It is the correct first test for a huge range of abdominal questions, and often the only one you will ever need. Radiographers and radiologists in the UK use it for gallstones, simple liver cysts, kidney size and hydronephrosis, bladder residual volumes, the abdominal aorta, spleen size and most pregnancy-related imaging.
Three situations where ultrasound is genuinely the right test and MRI adds nothing:
- Uncomplicated gallstone disease. Ultrasound picks up gallstones with over 95 per cent sensitivity. If the clinical question is "does this patient have gallstones", ultrasound answers it.
- A simple liver or kidney cyst on incidental imaging. If the ultrasound shows a thin-walled anechoic cyst with no septations, that is the diagnosis. MRI does not change management.
- Screening abdominal aortic aneurysm surveillance. The NHS AAA screening programme uses ultrasound for a reason - it is accurate, quick and free of contrast or radiation.
If your GP has ordered an ultrasound and you are wondering whether to push for MRI, the answer is usually no. Wait for the ultrasound. Escalate only if it is inconclusive or the symptoms do not fit the finding.
Where CT wins
CT is the workhorse of acute abdominal imaging. It scans the whole abdomen and pelvis in seconds, sees free air, free fluid, obstruction, bleeding, stones and abscess with high sensitivity, and is available in every A&E in the country at 3am.
CT is the right test when:
- The presentation is acute or traumatic. Suspected appendicitis, diverticulitis, bowel obstruction, ischaemic bowel, ruptured aneurysm or trauma - CT in minutes, decision in the same hour.
- Cancer staging needs speed and lung coverage. A staging CT of chest, abdomen and pelvis is the standard first pass because it captures lung metastases in the same acquisition. MRI cannot easily do the lungs.
- Renal or ureteric stones are the question. Non-contrast CT KUB is the gold standard.
The trade-off with CT is ionising radiation and, for most protocols, iodinated contrast. Both are safe when used appropriately, but the calculus changes for younger patients, pregnant patients and anyone facing repeat imaging over years. That is where MRI comes into its own. For the head-to-head, see our MRI vs CT breakdown.
Where abdominal MRI is the right test
Abdominal MRI earns its place when the question is character rather than presence. Ultrasound and CT are excellent at spotting things. MRI is what tells you what they are.
Liver lesions. An incidental liver lesion on ultrasound or CT is one of the most common triggers for an MRI referral in the UK. Multiphase MRI, and specifically MRI with a hepatocyte-specific contrast agent (Primovist / gadoxetate), can distinguish focal nodular hyperplasia from adenoma, cyst from cystic tumour, and haemangioma from metastasis with an accuracy CT often cannot match. For anyone with a background risk of hepatocellular carcinoma - cirrhosis, chronic hepatitis B or C - MRI is the surveillance modality of choice.
Pancreatic and biliary ducts. The pancreas is a difficult organ. It sits deep, moves with breathing, and is partly obscured by bowel gas on ultrasound. MRI with MRCP maps the pancreatic and common bile ducts in exquisite detail without a scope. It is the first-line investigation for suspected common bile duct stones, chronic pancreatitis, IPMN (intraductal papillary mucinous neoplasm) and pancreatic cystic lesions.
Kidney masses. When a renal mass is spotted on ultrasound or CT and the character is uncertain - a possible cystic tumour, a small enhancing lesion, a young patient with a genetic predisposition - MRI characterises without radiation and follows up over years safely. It is also the preferred modality when iodinated contrast is contraindicated by kidney function.
Adrenal lesions. Chemical shift MRI can tell a benign lipid-rich adenoma from a metastasis in a single acquisition. For the incidental adrenal nodule that CT cannot definitively call benign, MRI is often the deciding test.
Small bowel disease. MR enterography images the small bowel with a level of detail that CT cannot approach without repeated radiation. It is the standard of care for young patients with suspected or known Crohn's disease.
MRCP - the non-invasive alternative to ERCP
MRCP (magnetic resonance cholangiopancreatography) deserves its own section because it is one of the quiet revolutions in UK imaging. Twenty years ago, if a patient had a suspected common bile duct stone or an unexplained obstructive jaundice, they went for ERCP - an endoscope passed through the stomach and duodenum, a catheter into the ampulla, and dye injected up the biliary tree. It is a technically difficult procedure with a real complication rate: pancreatitis, bleeding, perforation.
MRCP does the diagnostic half of that job with a 15-minute MRI sequence and no injection, no sedation and no risk of pancreatitis. Water in the ducts lights up brightly against the surrounding tissue, and the whole biliary and pancreatic ductal tree is visualised. ERCP is now reserved almost exclusively for cases where an intervention is planned - removing a stone, placing a stent - not for diagnosis. If a UK gastroenterologist is asking whether there is a stone in your bile duct, MRCP is what they order.
MRCP is a good example of an imaging test earning its keep. It replaced a procedure that carried real risk with a scan that carries almost none, and the answer is often better.
MR enterography for Crohn's and UC
Inflammatory bowel disease is a young person's diagnosis. The average UK patient with Crohn's is diagnosed in their twenties, and will need imaging every few years for the rest of their life to monitor small bowel disease activity, strictures and fistulas. Doing that with CT means a cumulative radiation dose that any responsible radiologist wants to avoid.
MR enterography solves the problem. The patient drinks a litre of oral contrast that distends the small bowel, then has an MRI of the abdomen. The scan shows wall thickening, active inflammation, strictures, fistulas and abscess with a clarity CT cannot match, and can be repeated as often as clinically needed without any radiation cost. It is the gold-standard follow-up modality for Crohn's disease and increasingly for ulcerative colitis with small-bowel questions.
The trade-off is time. MR enterography takes 45 to 60 minutes in the scanner, plus 45 minutes of drinking the oral contrast beforehand. Plan for a two-hour visit. It is well worth it for the answer.
